Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 681

1.

Dental Education.

Ballard CW.

Am J Dent Sci. 1851 Oct;2(1):59-71. No abstract available.

2.

Treatment of Alveolar Abscess.

Ballard CW.

Am J Dent Sci. 1855 Jul;5(3):458-464. No abstract available.

3.

The relationship between the frequency of number puzzle use and baseline cognitive function in a large online sample of adults aged 50 and over.

Brooker H, Wesnes KA, Ballard C, Hampshire A, Aarsland D, Khan Z, Stenton R, Megalogeni M, Corbett A.

Int J Geriatr Psychiatry. 2019 Feb 11. doi: 10.1002/gps.5085. [Epub ahead of print]

PMID:
30746778
4.

Expression of neurogenic markers in Alzheimer's disease: a systematic review and metatranscriptional analysis.

Gatt A, Lee H, Williams G, Thuret S, Ballard C.

Neurobiol Aging. 2019 Jan 8;76:166-180. doi: 10.1016/j.neurobiolaging.2018.12.016. [Epub ahead of print]

PMID:
30716542
5.
6.

Treatment Combinations for Alzheimer's Disease: Current And Future Pharmacotherapy Options.

Cummings JL, Tong G, Ballard C.

J Alzheimers Dis. 2019 Jan 21. doi: 10.3233/JAD-180766. [Epub ahead of print]

PMID:
30689575
7.

Open-Label, Multicenter, Phase III Extension Study of Idalopirdine as Adjunctive to Donepezil for the Treatment of Mild-Moderate Alzheimer's Disease.

Frölich L, Atri A, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Geist MA, Raket LL, Cummings JL.

J Alzheimers Dis. 2019;67(1):303-313. doi: 10.3233/JAD-180595.

PMID:
30636738
8.

The Effect of a Multicomponent Intervention on Quality of Life in Residents of Nursing Homes: A Randomized Controlled Trial (COSMOS).

Husebø BS, Ballard C, Aarsland D, Selbaek G, Slettebo DD, Gulla C, Aasmul I, Habiger T, Elvegaard T, Testad I, Flo E.

J Am Med Dir Assoc. 2019 Jan 7. pii: S1525-8610(18)30638-8. doi: 10.1016/j.jamda.2018.11.006. [Epub ahead of print]

PMID:
30630722
9.

Survival time and differences between dementia with Lewy bodies and Alzheimer's disease following diagnosis: A meta-analysis of longitudinal studies.

Mueller C, Soysal P, Rongve A, Isik AT, Thompson T, Maggi S, Smith L, Basso C, Stewart R, Ballard C, O'Brien JT, Aarsland D, Stubbs B, Veronese N.

Ageing Res Rev. 2019 Jan 6;50:72-80. doi: 10.1016/j.arr.2019.01.005. [Epub ahead of print] Review.

PMID:
30625375
10.

Evaluation of powdered 0.5% chlorhexidine acetate-based postmilking teat dip compared with a foamed 1% iodine-based postmilking teat dip under cold weather conditions in northern New York.

Morrill KM, Scillieri Smith JC, Dann HM, Gauthier HM, Ballard CS.

J Dairy Sci. 2019 Mar;102(3):2507-2514. doi: 10.3168/jds.2018-15357. Epub 2019 Jan 3.

PMID:
30612797
11.

Pimavanserin in Alzheimer's Disease Psychosis: Efficacy in Patients with More Pronounced Psychotic Symptoms.

Ballard C, Youakim JM, Coate B, Stankovic S.

J Prev Alzheimers Dis. 2019;6(1):27-33. doi: 10.14283/jpad.2018.30.

PMID:
30569083
12.

Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program.

Cummings JL, Atri A, Ballard C, Boneva N, Frölich L, Molinuevo JL, Raket LL, Tariot PN.

Alzheimers Res Ther. 2018 Nov 24;10(1):116. doi: 10.1186/s13195-018-0443-2.

13.

Improving the quality of life of care home residents with dementia: Cost-effectiveness of an optimized intervention for residents with clinically significant agitation in dementia.

Romeo R, Zala D, Knapp M, Orrell M, Fossey J, Ballard C.

Alzheimers Dement. 2019 Feb;15(2):282-291. doi: 10.1016/j.jalz.2018.08.010. Epub 2018 Nov 20.

PMID:
30470592
14.

The Incidence of Recorded Delirium Episodes Before and After Dementia Diagnosis: Differences Between Dementia With Lewy Bodies and Alzheimer's Disease.

FitzGerald JM, Perera G, Chang-Tave A, Price A, Rajkumar AP, Bhattarai M, O'Brien JT, Ballard C, Aarsland D, Stewart R, Mueller C.

J Am Med Dir Assoc. 2018 Nov 15. pii: S1525-8610(18)30532-2. doi: 10.1016/j.jamda.2018.09.021. [Epub ahead of print]

PMID:
30448339
15.

An online investigation of the relationship between the frequency of word puzzle use and cognitive function in a large sample of older adults.

Wesnes KA, Brooker H, Ballard C, Hampshire A, Aarsland D, Khan Z, Stenton R, McCambridge L, Corbett A.

Int J Geriatr Psychiatry. 2018 Nov 15. doi: 10.1002/gps.5033. [Epub ahead of print]

PMID:
30443984
16.

Pimavanserin for Parkinson's Disease psychosis: Effects stratified by baseline cognition and use of cognitive-enhancing medications.

Espay AJ, Guskey MT, Norton JC, Coate B, Vizcarra JA, Ballard C, Factor SA, Friedman JH, Lang AE, Larsen NJ, Andersson C, Fredericks D, Weintraub D.

Mov Disord. 2018 Nov;33(11):1769-1776. doi: 10.1002/mds.27488. Epub 2018 Nov 2.

PMID:
30387904
17.

Protocol for the IDEAL-2 longitudinal study: following the experiences of people with dementia and their primary carers to understand what contributes to living well with dementia and enhances active life.

Silarova B, Nelis SM, Ashworth RM, Ballard C, Bieńkiewicz M, Henderson C, Hillman A, Hindle JV, Hughes JC, Lamont RA, Litherland R, Jones IR, Jones RW, Knapp M, Kotting P, Martyr A, Matthews FE, Morris RG, Quinn C, Regan J, Rusted JM, van den Heuvel EA, Victor CR, Wu YT, Clare L.

BMC Public Health. 2018 Oct 30;18(1):1214. doi: 10.1186/s12889-018-6129-7.

18.

Healthy adjustment for new residents with dementia using SettleIN: A feasibility study in UK care homes.

Hayward JK, Nunez KM, Ballard C, Spector A.

Dementia (London). 2018 Oct 24:1471301218806082. doi: 10.1177/1471301218806082. [Epub ahead of print]

PMID:
30354443
19.

Pimavanserin: Potential Treatment For Dementia-Related Psychosis.

Cummings J, Ballard C, Tariot P, Owen R, Foff E, Youakim J, Norton J, Stankovic S.

J Prev Alzheimers Dis. 2018;5(4):253-258. doi: 10.14283/jpad.2018.29.

PMID:
30298184
20.

Investigating the relationship between age of onset of depressive disorder and cognitive function.

Eraydin IE, Mueller C, Corbett A, Ballard C, Brooker H, Wesnes K, Aarsland D, Huntley J.

Int J Geriatr Psychiatry. 2019 Jan;34(1):38-46. doi: 10.1002/gps.4979. Epub 2018 Sep 27.

PMID:
30259558
21.

A role for APP in Wnt signalling links synapse loss with β-amyloid production.

Elliott C, Rojo AI, Ribe E, Broadstock M, Xia W, Morin P, Semenov M, Baillie G, Cuadrado A, Al-Shawi R, Ballard CG, Simons P, Killick R.

Transl Psychiatry. 2018 Sep 20;8(1):179. doi: 10.1038/s41398-018-0231-6.

22.

Predictors of Missed Hepatitis C Intake Appointments and Failure to Establish Hepatitis C Care Among Patients Living With HIV.

Cachay ER, Hill L, Torriani F, Ballard C, Grelotti D, Aquino A, Christopher Mathews W.

Open Forum Infect Dis. 2018 Jul 31;5(7):ofy173. doi: 10.1093/ofid/ofy173. eCollection 2018 Jul.

23.

Management of behavioral and psychological symptoms in people with Alzheimer's disease: an international Delphi consensus.

Kales HC, Lyketsos CG, Miller EM, Ballard C.

Int Psychogeriatr. 2019 Jan;31(1):83-90. doi: 10.1017/S1041610218000534. Epub 2018 Aug 2.

PMID:
30068400
24.

Ras-ERK-ETS inhibition alleviates neuronal mitochondrial dysfunction by reprogramming mitochondrial retrograde signaling.

Duncan OF, Granat L, Ranganathan R, Singh VK, Mazaud D, Fanto M, Chambers D, Ballard CG, Bateman JM.

PLoS Genet. 2018 Jul 30;14(7):e1007567. doi: 10.1371/journal.pgen.1007567. eCollection 2018 Jul.

25.

Advanced cerebral amyloid angiopathy and small vessel disease are associated with psychosis in Alzheimer's disease.

Vik-Mo AO, Bencze J, Ballard C, Hortobágyi T, Aarsland D.

J Neurol Neurosurg Psychiatry. 2018 Jul 27. pii: jnnp-2018-318445. doi: 10.1136/jnnp-2018-318445. [Epub ahead of print] No abstract available.

PMID:
30054314
26.

Executive function but not episodic memory decline associated with visual hallucinations in Parkinson's disease.

Creese B, Albertyn CP, Dworkin S, Thomas RS, Wan YM, Ballard C.

J Neuropsychol. 2018 Jul 23. doi: 10.1111/jnp.12169. [Epub ahead of print]

PMID:
30035858
27.

Impaired chronic pain-like behaviour and altered opioidergic system in the TASTPM mouse model of Alzheimer's disease.

Aman Y, Pitcher T, Ballard C, Malcangio M.

Eur J Pain. 2019 Jan;23(1):91-106. doi: 10.1002/ejp.1288. Epub 2018 Jul 30.

PMID:
29987897
28.

Course of neuropsychiatric symptoms in dementia: 5-year longitudinal study.

Vik-Mo AO, Giil LM, Ballard C, Aarsland D.

Int J Geriatr Psychiatry. 2018 Oct;33(10):1361-1369. doi: 10.1002/gps.4933. Epub 2018 Jul 6.

PMID:
29979473
29.

SIMBAD: a sequence-independent molecular-replacement pipeline.

Simpkin AJ, Simkovic F, Thomas JMH, Savko M, Lebedev A, Uski V, Ballard C, Wojdyr M, Wu R, Sanishvili R, Xu Y, Lisa MN, Buschiazzo A, Shepard W, Rigden DJ, Keegan RM.

Acta Crystallogr D Struct Biol. 2018 Jul 1;74(Pt 7):595-605. doi: 10.1107/S2059798318005752. Epub 2018 Jun 8.

30.

Associations between ZnT3, tau pathology, agitation, and delusions in dementia.

Whitfield DR, Francis PT, Ballard C, Williams G.

Int J Geriatr Psychiatry. 2018 Aug;33(8):1146-1152. doi: 10.1002/gps.4908. Epub 2018 Jun 1.

PMID:
29856089
31.

Tolerability of buprenorphine transdermal system in nursing home patients with advanced dementia: a randomized, placebo-controlled trial (DEP.PAIN.DEM).

Erdal A, Flo E, Aarsland D, Selbaek G, Ballard C, Slettebo DD, Husebo BS.

Clin Interv Aging. 2018 May 16;13:935-946. doi: 10.2147/CIA.S161052. eCollection 2018.

32.

Novel Treatment of Cryptococcal Meningitis via Neurapheresis Therapy.

Smilnak GJ, Charalambous LT, Cutshaw D, Premji AM, Giamberardino CD, Ballard CG, Bartuska AP, Ejikeme TU, Sheng H, Verbick LZ, Hedstrom BA, Pagadala PC, McCabe AR, Perfect JR, Lad SP.

J Infect Dis. 2018 Aug 24;218(7):1147-1154. doi: 10.1093/infdis/jiy286.

PMID:
29788431
33.

Hospitalization in people with dementia with Lewy bodies: Frequency, duration, and cost implications.

Mueller C, Perera G, Rajkumar AP, Bhattarai M, Price A, O'Brien JT, Ballard C, Stewart R, Aarsland D.

Alzheimers Dement (Amst). 2017 Dec 27;10:143-152. doi: 10.1016/j.dadm.2017.12.001. eCollection 2018.

34.

The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease.

Creese B, Da Silva MV, Johar I, Ballard C.

Expert Rev Neurother. 2018 Jun;18(6):461-467. doi: 10.1080/14737175.2018.1476140. Epub 2018 May 21.

PMID:
29764230
35.

Efficacy and Safety of Analgesic Treatment for Depression in People with Advanced Dementia: Randomised, Multicentre, Double-Blind, Placebo-Controlled Trial (DEP.PAIN.DEM).

Erdal A, Flo E, Aarsland D, Ballard C, Slettebo DD, Husebo BS.

Drugs Aging. 2018 Jun;35(6):545-558. doi: 10.1007/s40266-018-0546-2.

36.

Exploring the diet and lifestyle changes contributing to weight gain among Australian West African women following migration: A qualitative study.

Babatunde-Sowole OO, Power T, Davidson P, Ballard C, Jackson D.

Contemp Nurse. 2018 Apr;54(2):150-159. doi: 10.1080/10376178.2018.1459760. Epub 2018 Apr 10.

PMID:
29635959
37.

GDNF-expressing macrophages mitigate loss of dopamine neurons and improve Parkinsonian symptoms in MitoPark mice.

Chen C, Li X, Ge G, Liu J, Biju KC, Laing SD, Qian Y, Ballard C, He Z, Masliah E, Clark RA, O'Connor JC, Li S.

Sci Rep. 2018 Apr 3;8(1):5460. doi: 10.1038/s41598-018-23795-4.

38.

Distributed computing for macromolecular crystallography.

Krissinel E, Uski V, Lebedev A, Winn M, Ballard C.

Acta Crystallogr D Struct Biol. 2018 Feb 1;74(Pt 2):143-151. doi: 10.1107/S2059798317014565. Epub 2018 Feb 1.

39.

CCP4i2: the new graphical user interface to the CCP4 program suite.

Potterton L, Agirre J, Ballard C, Cowtan K, Dodson E, Evans PR, Jenkins HT, Keegan R, Krissinel E, Stevenson K, Lebedev A, McNicholas SJ, Nicholls RA, Noble M, Pannu NS, Roth C, Sheldrick G, Skubak P, Turkenburg J, Uski V, von Delft F, Waterman D, Wilson K, Winn M, Wojdyr M.

Acta Crystallogr D Struct Biol. 2018 Feb 1;74(Pt 2):68-84. doi: 10.1107/S2059798317016035. Epub 2018 Feb 1.

40.

Recent developments in MrBUMP: better search-model preparation, graphical interaction with search models, and solution improvement and assessment.

Keegan RM, McNicholas SJ, Thomas JMH, Simpkin AJ, Simkovic F, Uski V, Ballard CC, Winn MD, Wilson KS, Rigden DJ.

Acta Crystallogr D Struct Biol. 2018 Mar 1;74(Pt 3):167-182. doi: 10.1107/S2059798318003455. Epub 2018 Mar 6.

41.

Alcohol and dementia: a complex relationship with potential for dementia prevention.

Ballard C, Lang I.

Lancet Public Health. 2018 Mar;3(3):e103-e104. doi: 10.1016/S2468-2667(18)30031-8. Epub 2018 Feb 21. No abstract available.

42.

A roadmap to advance dementia research in prevention, diagnosis, intervention, and care by 2025.

Pickett J, Bird C, Ballard C, Banerjee S, Brayne C, Cowan K, Clare L, Comas-Herrera A, Corner L, Daley S, Knapp M, Lafortune L, Livingston G, Manthorpe J, Marchant N, Moriarty J, Robinson L, van Lynden C, Windle G, Woods B, Gray K, Walton C.

Int J Geriatr Psychiatry. 2018 Jul;33(7):900-906. doi: 10.1002/gps.4868. Epub 2018 Feb 22.

43.

Evaluation of the safety, tolerability, and efficacy of pimavanserin versus placebo in patients with Alzheimer's disease psychosis: a phase 2, randomised, placebo-controlled, double-blind study.

Ballard C, Banister C, Khan Z, Cummings J, Demos G, Coate B, Youakim JM, Owen R, Stankovic S; ADP Investigators.

Lancet Neurol. 2018 Mar;17(3):213-222. doi: 10.1016/S1474-4422(18)30039-5. Erratum in: Lancet Neurol. 2018 Feb 26;:.

PMID:
29452684
44.

Impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes: A cluster-randomised controlled trial.

Ballard C, Corbett A, Orrell M, Williams G, Moniz-Cook E, Romeo R, Woods B, Garrod L, Testad I, Woodward-Carlton B, Wenborn J, Knapp M, Fossey J.

PLoS Med. 2018 Feb 6;15(2):e1002500. doi: 10.1371/journal.pmed.1002500. eCollection 2018 Feb.

45.

Importance of Proactive Treatment of Depression in Lewy Body Dementias: The Impact on Hippocampal Neurogenesis and Cognition in a Post-Mortem Study.

Gatt A, Ekonomou A, Somani A, Thuret S, Howlett D, Corbett A, Johnson M, Perry E, Attems J, Francis P, Aarsland D, Ballard C.

Dement Geriatr Cogn Disord. 2017;44(5-6):283-293. doi: 10.1159/000484437. Epub 2018 Jan 27.

PMID:
29393203
46.

Limited Accuracy of Administrative Data for the Identification and Classification of Adult Congenital Heart Disease.

Khan A, Ramsey K, Ballard C, Armstrong E, Burchill LJ, Menashe V, Pantely G, Broberg CS.

J Am Heart Assoc. 2018 Jan 12;7(2). pii: e007378. doi: 10.1161/JAHA.117.007378.

47.

Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach.

Bereczki E, Branca RM, Francis PT, Pereira JB, Baek JH, Hortobágyi T, Winblad B, Ballard C, Lehtiö J, Aarsland D.

Brain. 2018 Feb 1;141(2):582-595. doi: 10.1093/brain/awx352.

48.

(-)-Phenserine and Inhibiting Pre-Programmed Cell Death: In Pursuit of a Novel Intervention for Alzheimer's Disease.

Becker RE, Greig NH, Lahiri DK, Bledsoe J, Majercik S, Ballard C, Aarsland D, Schneider LS, Flanagan D, Govindarajan R, Sano M, Ferrucci L, Kapogiannis D.

Curr Alzheimer Res. 2018;15(9):883-891. doi: 10.2174/1567205015666180110120026.

49.

Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials.

Atri A, Frölich L, Ballard C, Tariot PN, Molinuevo JL, Boneva N, Windfeld K, Raket LL, Cummings JL.

JAMA. 2018 Jan 9;319(2):130-142. doi: 10.1001/jama.2017.20373.

50.

Mitochondrial Translocase of the Outer Membrane Alterations May Underlie Dysfunctional Oxidative Phosphorylation in Alzheimer's Disease.

Chai YL, Xing H, Chong JR, Francis PT, Ballard CG, Chen CP, Lai MKP.

J Alzheimers Dis. 2018;61(2):793-801. doi: 10.3233/JAD-170613.

PMID:
29254089

Supplemental Content

Loading ...
Support Center